Treatment of fetishism with naltrexone: A case report

Firoz, K.; Sankar, V. Nidheesh; Rajmohan, V; Kumar, G. Manoj; Raghuram, Thazhe Mangool

doi:10.1016/j.ajp.2013.11.006

Cited by 10 publications

(3 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Both naltrexone and topiramate have well-established roles in the treatment of impulsive, compulsive, and addictive disorders. Among the paraphilias, both naltrexone and topiramate have been used successfully to treat sexual fetishism 3,4 . Naltrexone has also been used to treat adolescent sex offenders, although specific paraphilic behaviors in this sample, if any, were not specified 5 .…”

Section: Discussionmentioning

confidence: 94%

Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder

Blum

Grant

2021

J Clin Psychopharmacol

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 94%

Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder

Blum

Grant

2021

J Clin Psychopharmacol

View full text Add to dashboard Cite

“…Evidence concerning other biomedical treatment options for paraphilia is very scare, especially for individuals with comorbid psychiatric disorders. Firoz et al [33] reported a case of fetishism with comorbid substance abuse that was successfully treated with naltrexone. Ingves et al [34] reported the successful treatment of a 67-year-old man suffering from depression, obsessive-compulsive disorder, and signs of frontotemporal dementia with a course of electroconvulsive therapy.…”

Section: Therapeutic Approachmentioning

confidence: 98%

Paraphilias

Konrad

Welke

Opitz‐Welke

2015

Current Opinion in Psychiatry

View full text Add to dashboard Cite

show abstract

“…Naltrexone Naltrexone is a long-acting opioid antagonist used clinically in the treatment of alcohol dependence or drug abuse, which inhibits dopamine release in the nucleus accumbens. Firoz et al (2014) reported naltrexone efficacy in one case of fetishism with comorbid substance use.…”

Section: Tricyclic Antidepressants and Mirtazapinementioning

confidence: 99%

The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders

Thibaut

Cosyns

Fedoroff

et al. 2020

The World Journal of Biological Psychiatry

View full text Add to dashboard Cite

The primary aim of these guidelines is to evaluate the role of pharmacological agents in the treatment and management of patients with paraphilic disorders, with a focus on the treatment of adult males. Because such treatments are not delivered in isolation, the role of specific psychotherapeutic interventions is also briefly covered. These guidelines are intended for use in clinical practice by clinicians who diagnose and treat patients, including sexual offenders, with paraphilic disorders. The aim of these guidelines is to bring together different views on the appropriate treatment of paraphilic disorders from experts representing different countries in order to aid physicians in clinical decisions and to improve the quality of care. Methods: An extensive literature search was conducted using the English-language-literature indexed on MEDLINE/PubMed (1990-2018 for SSRIs) (1969-2018 for hormonal treatments), supplemented by other sources, including published reviews. Results: Each treatment recommendation was evaluated and discussed with respect to the strength of evidence for its efficacy, safety, tolerability, and feasibility. The type of medication used depends on the severity of the paraphilic disorder and the respective risk of behavior endangering others. GnRH analogue treatment constitutes the most relevant treatment for patients with severe paraphilic disorders. Conclusions: An algorithm is proposed with different levels of treatment for different categories of paraphilic disorders accompanied by different risk levels.

show abstract

Treatment of fetishism with naltrexone: A case report

Cited by 10 publications

References 7 publications

Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder

Use of Anticraving Agents in the Treatment of Exhibitionism and Frotteuristic Disorder

Paraphilias

The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders

Contact Info

Product

Resources

About